Status:
UNKNOWN
Cyanophyta Aphanizomenon Flos-aquae, and Adipose Stroma Vascular Fraction, in Heart Failure Patient
Lead Sponsor:
Sociedad Española de Medicina Regenerativa y Terapia Celular
Collaborating Sponsors:
Clinica Castello 68
Conditions:
Congestive Heart Failure Chronic
Eligibility:
All Genders
35-80 years
Brief Summary
This study is a prospective, randomized, controlled trial to assess the efficacy of transplantation of autologous stroma vauscultar fraction and/or AFA in 15 patients with ischemic heart failure
Detailed Description
Stem cells therapy may be a choice therapy for advanced heart failure patients refractory to medical therapy, and a previous history of coronary artery diseases. In this study the investigators have e...
Eligibility Criteria
Inclusion
- EF \< 45 %
- NYHA 2 - 3
Exclusion
- Acute coronary syndrome within last 6 weeks.
- Pregnancy
- FEV1 \<20 %
- Cancer
- Any severe disease which could interfere with the treatment or the outcome
- Patient with immunodeficiency
- Candidate who are judged to be not applicable to this study by doctors.
Key Trial Info
Start Date :
May 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04515537
Start Date
May 20 2021
End Date
September 30 2023
Last Update
January 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinca Castello 68
Madrid, Spain, 28001